ondansetron has been researched along with Sarcoma, Epithelioid in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide was administered at the daily dose of 1200 mg/m2/24 h." | 1.29 | [Peri-operative chemotherapy during resection of pulmonary metastases of sarcoma]. ( Azorin, JF; Delepine, G; Delepine, N; Destable, MD; Pocard, M; Tremblay, B, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pillai, AK | 1 |
| Sharma, KK | 1 |
| Gupta, YK | 1 |
| Bakhshi, S | 1 |
| Pocard, M | 1 |
| Azorin, JF | 1 |
| Delepine, N | 1 |
| Delepine, G | 1 |
| Tremblay, B | 1 |
| Destable, MD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Study to Evaluate the Anti-Emetic Effect of Ginger Powder Vs Placebo as an Add-on Therapy in Children and Adolescents Receiving Chemotherapy : A Randomized Controlled Trial[NCT00940368] | Phase 3 | 60 participants (Anticipated) | Interventional | 2009-06-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ondansetron and Sarcoma, Epithelioid
| Article | Year |
|---|---|
Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisp | 2011 |
1 other study available for ondansetron and Sarcoma, Epithelioid
| Article | Year |
|---|---|
[Peri-operative chemotherapy during resection of pulmonary metastases of sarcoma].
Topics: Adult; Combined Modality Therapy; Female; Humans; Ifosfamide; Infusions, Intravenous; Intraoperative | 1994 |